J&J(JNJ) - 2024 Q2 - Earnings Call Presentation

2nd Quarter 2024 Results¹ 2nd Quarter 2024 Sales Worldwide increased ▲ Excluding acquisitions / divestitures on an operational basis Worldwide increased ▲ Diluted earnings per share Adjusted diluted earnings per share* Increased ▲ 10.2% Joaquin Duato Chairman & Chief Executive Officer Johnson & Johnson 66 Johnson & Johnson's second quarter performance reflects our relentless focus on advancing the next wave of medical innovation and resulted in strong sales and adjusted operational earnings per share growth ...